CDK Inhibitors approved by Pharmaceutical Benefits Advisory Committee (PBAC) but cost is still an issue
See the link below for further informationhttps://www.bcna.org.au/news/2018/04/cdk-inhibitors-approved-by-pbac-but-costs-still-an-issue/
Published 8 years ago
Version 1.0Giovanna_BCNA
Member
Joined September 21, 2017
News and events
Follow this blog board to get notified when there's new activity